Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Repligen
77
Repligen
Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
I work here
Suggest edits
repligen.com
Technology
>
Biotechnology
Life Sciences
B2c
Founded in
1981
Raised
$4M
More info
Elsewhere
Companies in the same industry
PharmaVOICE
Novalact
Diagenode
Paragon Genomics
JumpStartInc
Agilent Technologies
PATHSENSORS
Avitide, Inc.
Securus Medical Group
Avadim Technologies, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Venture capital
$4,000,000
Employees
Team size
50+
Locations
Unknown
Help us complete this profile
The Motley Fool
Read This Before You Sell Repligen Corporation Stock
The Motley Fool
Repligen Corporation Jumped 14.6% in February -- Here's Why
The Motley Fool
Why Repligen Corporation Shares Are Falling --
PharmaVOICE
Novalact
Diagenode
Paragon Genomics
JumpStartInc
Agilent Technologies
PATHSENSORS
Avitide, Inc.
Securus Medical Group
Avadim Technologies, Inc.